Figure 1.
Figure 1. Expression of the fractalkine receptor (CX3CR1) on platelets demonstrated by Western blot (human platelets) or flow cytometry analysis (rat platelets). (A) Western blot demonstrating CX3CR1 expression on human washed platelets compared with peripheral blood mononuclear cells (PBMCs) and human spleen lysate as a positive control for CX3CR1. (B) The expression of CX3CR1 was similar in platelets from healthy Wistar-Kyoto rats (WKY) in the absence or presence of stimulation with adenosine diphosphate (ADP). The flow cytometry data are expressed as mean fluorescence ± SEM from 6 separate experiments. (C) A typical flow cytometry histogram with background (fine) and CX3CR1 expression (bold) on platelets from Wistar-Kyoto rats.

Expression of the fractalkine receptor (CX3CR1) on platelets demonstrated by Western blot (human platelets) or flow cytometry analysis (rat platelets). (A) Western blot demonstrating CX3CR1 expression on human washed platelets compared with peripheral blood mononuclear cells (PBMCs) and human spleen lysate as a positive control for CX3CR1. (B) The expression of CX3CR1 was similar in platelets from healthy Wistar-Kyoto rats (WKY) in the absence or presence of stimulation with adenosine diphosphate (ADP). The flow cytometry data are expressed as mean fluorescence ± SEM from 6 separate experiments. (C) A typical flow cytometry histogram with background (fine) and CX3CR1 expression (bold) on platelets from Wistar-Kyoto rats.

Close Modal

or Create an Account

Close Modal
Close Modal